Four Geisel School of Medicine students presented their research at April’s Medical Student Grand Rounds at DHMC. Their work spanned three projects: RNA-based biomarkers to guide tarlatamab therapy in small cell lung cancer; treatment exposures and disease severity among rural New England patients with a chronic inflammatory skin disorder; and a data analysis of how rural health systems have underutilized of the Northern New England 24-Hour Ambulatory Blood Pressure Monitoring Registry.
Dartmouth Cancer Center (DCC) has appointed Roy Herbst as the center’s sixth director. Herbst will lead integrated efforts to help strengthen cancer research, education, and collaboration across Dartmouth and Dartmouth Health. Interim DCC Director Konstantin Dragnev was also recognized for his dedicated and thoughtful leadership during the transition.
A $1.5M National Cancer Institute grant to Saeed Hassanpour of Dartmouth’s Norris Cotton Cancer Center will be used to build new artificial intelligence (AI) technologies for precision cancer care in lung cancer management.
Large study co-led by Geisel professor Christopher Amos, PhD, identified several new variants for lung cancer risk that will translate into improved understanding of the mechanisms involved in lung cancer risk.
Dartmouth researchers say lung cancer screening in the National Lung Screening Trial (NLST) meets a commonly accepted standard for cost effectiveness as reported in the Nov. 6 issue of the New England Journal of Medicine.
New research by an international group of scientists confirms a vulnerability to lung cancer can be inherited and implicates the BRCA2 gene as harboring one of the involved genetic mutations.
This page may link to PDF files. Use this link to download Adobe Reader if needed.